Antibody responses to the HIV-1 envelope high mannose patch.

Area of Science:

• Immunology
• Virology
• Glycobiology

Background:

• Human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) is heavily glycosylated, presenting a significant challenge for antibody recognition.
• Host-derived glycans on HIV-1 Env form a 'glycan shield', complicating the induction of effective anti-glycan antibodies without autoreactivity.
• Despite challenges, the host immune system can generate neutralizing antibodies that target Env glycans during HIV-1 infection.

Purpose of the Study:

• To categorize distinct classes of HIV-1 glycan-dependent antibodies based on paratope structure, neutralization activity, and reactivity.
• To compare and contrast these antibody classes targeting the high mannose patch on HIV-1 Env.
• To describe vaccine design strategies aimed at eliciting these specific antibody types.

Main Methods:

• Analysis of antibody paratope structure.
• Assessment of neutralization activity against HIV-1.
• Evaluation of glycan and peptide reactivity of antibodies.

Main Results:

• A cluster of high mannose glycans, the 'high mannose patch' (including glycan at position 332), is a key target for broadly neutralizing antibodies.
• HIV-1 glycan-dependent antibodies targeting the high mannose patch can be classified into distinct categories.
• These categories differ in paratope structure, neutralization potency, and specific binding profiles.

Conclusions:

• Understanding the distinct classes of glycan-targeting antibodies is crucial for developing effective HIV-1 vaccines.
• Vaccine design efforts are focused on eliciting antibodies that target specific glycan structures on the HIV-1 Env.
• Targeting the high mannose patch represents a promising strategy for inducing broadly neutralizing antibodies against HIV-1.